Drug pricing: Price war intensifies between Europe and the United States
Pharmaceutical companies threaten to delay launching new drugs in Europe.
Published 3sem1 sourceNotable
Lire en français
≈ 17s
The fact
French prices, 30-50% lower than US rates, become a strategic issue.
The EU considers protection mechanisms to ensure access to innovative treatments.
Click the link to read an article on the topic: